SCHEMBL7574752

SCHEMBL7574752

Cc1cccc(NC(C(=O)O)c2ccccc2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 3/20 0.53
HSD17B10 Q99714 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.48
MEN1 O00255 5/20 0.48
KMT2A Q03164 5/20 0.48
ALDH1A1 P00352 1/20 0.48
GAA P10253 1/20 0.47
EGFR P00533 1/20 0.46
MMP1 P03956 1/20 0.46
MMP2 P08253 1/20 0.46
MMP9 P14780 1/20 0.46
MAOA P21397 1/20 0.46
MAOB P27338 1/20 0.46
POLB P06746 3/20 0.45
KCNK3 O14649 1/20 0.45
KCNK9 Q9NPC2 1/20 0.45
RXFP1 Q9HBX9 1/20 0.45
HTT P42858 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7583591 0.87 TDP1 (0.50) MEN1KMT2AALDH1A1HTTCYP2D6
SCHEMBL2483519 0.82 FPR2 (0.49) HSD17B10ALDH1A1POLBCYP2D6LMNA
SCHEMBL2483521 0.82 FPR2 (0.49) HSD17B10ALDH1A1POLBCYP2D6LMNA
SCHEMBL146704 0.82 FPR2 (0.49) HSD17B10ALDH1A1POLBCYP2D6LMNA
SCHEMBL7574163 0.82 CYP3A4 (0.55) HSD17B10MEN1KMT2AALDH1A1MMP1
SCHEMBL20335082 0.82 FPR2 (0.59) HSD17B10L3MBTL1MEN1KMT2AALDH1A1
SCHEMBL3904896 0.81 HPGD (0.48) MEN1KMT2AALDH1A1LMNAMAPT
SCHEMBL2482091 0.81 SMN1; SMN2 (0.53) MEN1KMT2AALDH1A1GAAHTT
SCHEMBL16664412 0.81 HSD17B10 (0.53) HSD17B10L3MBTL1MEN1KMT2AALDH1A1
SCHEMBL2993388 0.81 POLB (0.65) L3MBTL1MEN1KMT2AALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242069-A2 ALBUMIN-BINDING COMPOUNDS THAT PREVENT NONENZYMATIC GLYCATION AND THAT MAY BE USED FOR TREATMENT OF GLYCATION-RELATED PATHOLOGIES EXOCELL, INC. (US) 2002-09-25 EP disclosed
WO-2001003684-A2 ALBUMIN-BINDING COMPOUNDS THAT PREVENT NONENZYMATIC GLYCATION AND THAT MAY BE USED FOR TREATMENT OF GLYCATION-RELATED PATHOLOGIES EXOCELL, INC. (US) 2001-01-18 WO disclosed